Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
|
|
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
|
|
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
|
|
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
|
|
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Moderately selective blockade of NET and SERT Acute increase in serotonergic and adrenergic synaptic activity (otherwise like SSRIs)
|
Many of serotonergic adverse effects associated with SSRIs
Depression in children
Loss of libido
Noradrenergic effects: ↑BP, ↑HR,
CNS effects: insomnia, anxiety
|
Major depression, chronic pain disorders, fibromyalgia, perimenopausal symptoms
|
|
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Moderately selective blockade of NET and SERT Acute increase in serotonergic and adrenergic synaptic activity (otherwise like SSRIs)
|
Many of serotonergic adverse effects associated with SSRIs
Depression in children
Loss of libido
Noradrenergic effects: ↑BP, ↑HR,
CNS effects: insomnia, anxiety
|
Major depression, chronic pain disorders, fibromyalgia, perimenopausal symptoms
|
|
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Tricyclic Antidepressants (TCAs)
Mixed and variable blockade of NET and SERT Lite SNRIs plus significant blockade of autonomic nervous system and histamine receptors
|
Anticholinergic effects: dry mouth, constipation, urinary retention, blurred bison, confusion
α-blocking effects: orthostatic hypotension H1 antagonism: weight gain, sedation
arrhythmias
|
Major depression not response to other drugs, chronic pain disorders, incontinence, obsessive compulsive disorder
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
5-HT2 Antagonists
Inhibition of 5-HT2A receptor Forms a metabolite (m-cpp) that blocks 5-HT2A,2C receptors
|
H1 receptor blockade: sedation,
α receptor blockade: orthostatic hypotension
GI effects
|
Major depression, used for sedation and hypnosis insomnia
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Momoamine Oxidase Inhibitors (MAOIs)
Irreversible, nonselective blockade of MAO-A and MAO-B
|
Anticholinergic effects
Orthostatic hypotension and weight gain are most common highest rates of sexual effects of all antidepressants restlessness, insomnia
|
Major depression unresponsive to other drugs
|
|
|
|